In December 2007 Sun Biomedical Limited (SBN or the Company) entered into a joint venture with Shanghai Siyi Biotechnology Co. Ltd (Siyi), a China based company, for the assembly and sale of OraLine products for use by the Chinese Ministry of Public Security (MPS) and future nongovernmental customers.
- Forums
- ASX - By Stock
- SBN
- chinese approval
chinese approval, page-26
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online